Dear Colleagues,

It is with great pleasure that we invite you to attend The 3rd International Virtual Congress on Controversies in Fibromyalgia (Fibromyalgia2021) which will take place 24-25 June 2021.

 

Even as our understanding regarding the pathogenesis and neuroscience underlying fibromyalgia and chronic pain rapidly expand and proliferate in recent years, heated controversies remain regarding many aspects of fibromyalgia, regarding its place in medicine and society and regarding the best ways to alleviate suffering.

 

                              Dr. Jacob Ablin
          Tel-Aviv Sourasky Medical Center, Israel
                              Congress Co-Chair

 

                        Prof. Piercarlo Sarzi-Puttini
                L. Sacco University Hospital, Milan, Italy
                                    Congress Co-Chair

 

 

READ MORE

VIRTUAL CONGRESS

Unique Learning Experience for Medical Professionals

REGISTER NOW

Regular Registration Deadline:
31 May 2021

SPONSORSHIP PROSPECTUS

View Sponsorship
Opportunities

EXHIBITION OPPORTUNITY

Join us as an Exhibitor
Special Price of €750

Meet the Speakers

Daniel Clauw

University of Michigan, USA

Daniel Clauw, M.D is a Professor of Anesthesiology, Medicine and Psychiatry at the University of Michigan. He attended undergrad and… READ MORE
Mary-Ann Fitzcharles

McGill University, Canada

Mary-Ann Fitzcharles has worked as a clinician, teacher and clinical researcher at McGill University, Montreal Canada since 1982. She completed… READ MORE
Bart Morlion

Leuven Centre for Algology & Pain Management, University Hospitals of Leuven, Belgium

Bart Morlion trained as an anaesthesiologist but works since many years full time in pain medicine. He is the director… READ MORE
Serge Perrot

Cochin University Hospital, France

Serge Perrot is Rheumatologist and Pain Specialist He is currently Professor of Clinical Pharmacology at Paris University, and head of… READ MORE
All Speakers

Congress Program

Contact Us

Please drop us a line with any questions or comments you may have.

We look forward to hearing from you.